Collegium Pharmaceutical
COLL
COLL
140 hedge funds and large institutions have $773M invested in Collegium Pharmaceutical in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.44% more ownership
Funds ownership: 87.53% → 91.97% (+4.4%)
10% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 41
42% less call options, than puts
Call options by funds: $1.29M | Put options by funds: $2.25M
Holders
140
Holding in Top 10
5
Calls
$1.29M
Puts
$2.25M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$13.7M | |
| 3 | +$9.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.31M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$5.72M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$9.76M | |
| 3 | -$7.05M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.86M |
| 5 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$4.21M |